|
1
|
Khosravi AD, Shafie F, Abbasi Montazeri E
and Rostami S: The frequency of genes encoding exotoxin A and
exoenzyme S in Pseudomonas aeruginosa strains isolated from
burn patients. Burns. 42:1116–1120. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Leseva M, Arguirova M, Nashev D, Zamfirova
E and Hadzhyiski O: Nosocomial infections in burn patients:
Etiology, antimicrobial resistance, means to control. Ann Burns
Fire Disasters. 26:5–11. 2013.PubMed/NCBI
|
|
3
|
Liu PY, Sun YX, Gu DQ and Cheng JL: Drug
resistance of imipenem-resistant Gram-negative bacilli in coal
worker's pneumoconiosis chronic obstructive pulmonary disease
patients with lower respiratory tract infection. Zhonghua Lao Dong
Wei Sheng Zhi Ye Bing Za Zhi. 31:700–702. 2013.PubMed/NCBI(In Chinese).
|
|
4
|
Gales AC, Jones RN and Sader HS: Global
assessment of the antimicrobial activity of polymyxin B against 54
731 clinical isolates of Gram-negative bacilli: Report from the
SENTRY antimicrobial surveillance programme (2001-2004). Clin
Microbiol Infect. 12:315–321. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Vaez H, Moghim S, Nasr Esfahani B and
Ghasemian Safaei H: Clonal relatedness among imipenem-resistant
Pseudomonas aeruginosa isolated from ICU-hospitalized
patients. Crit Care Res Pract. 2015(983207)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wilhelm CM, Nunes LS, Martins AF and Barth
AL: In vitro antimicrobial activity of imipenem plus amikacin or
polymyxin B against carbapenem-resistant Pseudomonas
aeruginosa isolates. Diagn Microbiol Infect Dis. 92:152–154.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nation RL, Velkov T and Li J: Colistin and
polymyxin B: Peas in a pod, or chalk and cheese? Clin Infect Dis.
59:88–94. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lim TP, Lee W, Tan TY, Sasikala S, Teo J,
Hsu LY, Tan TT, Syahidah N and Kwa AL: Effective antibiotics in
combination against extreme drug-resistant Pseudomonas
aeruginosa with decreased susceptibility to polymyxin B. PLoS
One. 6(e28177)2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bakthavatchalam YD and Veeraraghavan B:
Challenges, issues and warnings from CLSI and EUCAST working group
on polymyxin susceptibility testing. J Clin Diagn Res.
11:DL03–DL04. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Simar S, Sibley D, Ashcraft D and Pankey
G: Colistin and polymyxin B minimal inhibitory concentrations
determined by Etest found unreliable for Gram-negative bacilli.
Ochsner J. 17:239–242. 2017.PubMed/NCBI
|
|
11
|
Nhung PH, Miyoshi-Akiyama T, Phuong DM,
Shimada K, Anh NQ, Binh NG, Thanh do V, Ohmagari N and Kirikae T:
Evaluation of the Etest method for detecting colistin
susceptibility of multidrug-resistant Gram-negative isolates in
Vietnam. J Infect Chemother. 21:617–619. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kulengowski B, Ribes JA and Burgess DS:
Polymyxin B Etest® compared with gold-standard broth
microdilution in carbapenem-resistant Enterobacteriaceae exhibiting
a wide range of polymyxin B MICs. Clin Microbiol Infect. 25:92–95.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
16
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Landman D, Bratu S, Alam M and Quale J:
Citywide emergence of Pseudomonas aeruginosa strains with
reduced susceptibility to polymyxin B. J Antimicrob Chemother.
55:954–957. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun
JY, Yu YS, Kong HS, He L, Wu WY, et al: Surveillance of
antimicrobial resistance among nosocomial gram-negative pathogens
from 15 teaching hospitals in China in 2005. Zhonghua Yi Xue Za
Zhi. 87:2753–2758. 2007.PubMed/NCBI(In Chinese).
|
|
19
|
Kirby JT, Fritsche TR and Jones RN:
Influence of patient age on the frequency of occurrence and
antimicrobial resistance patterns of isolates from
hematology/oncology patients: Report from the chemotherapy alliance
for neutropenics and the control of emerging resistance program
(North America). Diagn Microbiol Infect Dis. 56:75–82.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
van der Heijden IM, Levin AS, De Pedri EH,
Fung L, Rossi F, Duboc G, Barone AA and Costa SF: Comparison of
disc diffusion, Etest and broth microdilution for testing
susceptibility of carbapenem-resistant P. aeruginosa to
polymyxins. Ann Clin Microbiol Antimicrob. 6(8)2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Raja NS and Singh NN: Antimicrobial
susceptibility pattern of clinical isolates of Pseudomonas
aeruginosa in a tertiary care hospital. J Microbiol Immunol
Infect. 40:45–49. 2007.PubMed/NCBI
|
|
22
|
Tan TY, Hsu LY, Koh TH, Ng LS, Tee NW,
Krishnan P, Lin RT and Jureen R: Antibiotic resistance in
gram-negative bacilli: A Singapore perspective. Ann Acad Med
Singapore. 37:819–825. 2008.PubMed/NCBI
|
|
23
|
Scheffer MC, Bazzo ML, Steindel M, Darini
AL, Climaco E and Dalla-Costa LM: Intrahospital spread of
carbapenem-resistant Pseudomonas aeruginosa in a university
hospital in Florianópolis, Santa Catarina, Brazil. Rev Soc Bras Med
Trop. 43:367–371. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tam VH, Chang KT, Abdelraouf K, Brioso CG,
Ameka M, McCaskey LA, Weston JS, Caeiro JP and Garey KW:
Prevalence, resistance, mechanisms and susceptibility of
multidrug-resistant bloodstream isolates of Pseudomonas
aeruginosa. Antimicrob Agents Chemother. 54:1160–1164.
2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cereda RF, Azevedo HD, Girardello R,
Xavier DE and Gales AC: INVITA-A-CEFTO Brazilian Study Group.
Antimicrobial activity of ceftobiprole against gram-negative and
gram-positive pathogens: Results from INVITA-A-CEFTO Brazilian
study. Braz J Infect Dis. 15:339–348. 2011.PubMed/NCBI
|
|
26
|
Liu YN, Cao B, Wang H, Chen LA, She DY,
Zhao TM, Liang ZX, Sun TY, Li YM, Tong ZH, et al: Adult hospital
acquired pneumonia: a multicenter study on microbiology and
clinical characteristics of patients from 9 Chinese cities.
Zhonghua Jie He He Hu Xi Za Zhi. 35:739–746. 2012.PubMed/NCBI(In Chinese).
|
|
27
|
Memish ZA, Shibl AM, Kambal AM, Ohaly YA,
Ishaq A and Livermore DM: Antimicrobial resistance among
non-fermenting Gram-negative bacteria in Saudi Arabia. J Antimicrob
Chemother. 67:1701–1705. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Haeili M, Ghodousi A, Nomanpour B, Omrani
M and Feizabadi MM: Drug resistance patterns of bacteria isolated
from patients with nosocomial pneumonia at Tehran hospitals during
2009-2011. J Infect Dev Ctries. 7:312–317. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Q, Zhao CJ, Wang H, Yu YS, Zhu ZH,
Chu YZ, Sun ZY, Hu ZD, Xu XL, Liao K, et al: Antimicrobial
resistance of Gram-negative bacilli isolated from 13 teaching
hospitals across China. Zhonghua Yi Xue Za Zhi. 93:1388–1396.
2013.PubMed/NCBI(In Chinese).
|
|
30
|
Xiao H, Ye X, Liu Q and Li L: Antibiotic
susceptibility and genotype patterns of Pseudomonas
aeruginosa from mechanical ventilation-associated pneumonia in
intensive care units. Biomed Rep. 1:589–593. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ali Z, Mumtaz N, Naz SA, Jabeen N and
Shafique M: Multi-drug resistant pseudomonas aeruginosa: a threat
of nosocomial infections in tertiary care hospitals. J Pak Med
Assoc. 65:12–16. 2015.PubMed/NCBI
|
|
32
|
Ameen N, Memon Z, Shaheen S, Fatima G and
Ahmed F: Imipenem Resistant Pseudomonas aeruginosa: The fall
of the final quarterback. Pak J Med Sci. 31:561–565.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Habibi A and Honarmand R: Profile of
Virulence Factors in the Multi-Drug Resistant Pseudomonas
aeruginosa Strains of Human Urinary Tract Infections (UTI).
Iran Red Crescent Med J. 17(e26095)2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang Q, Wang H, Yu Y, Xu X, Sun Z, Lu J,
Yang B, Zhang L, Hu Z, Feng X, et al: Antimicrobial resistance
monitoring of gram-negative bacilli isolated from 15 teaching
hospitals in 2014 in China. Zhonghua Nei Ke Za Zhi. 54:837–845.
2015.PubMed/NCBI(In Chinese).
|
|
35
|
Zhang JF, Zhu HY, Sun YW, Liu W, Huo YM,
Liu DJ, Li J and Hua R: Pseudomonas aeruginosa infection
after pancreatoduodenectomy: risk factors and clinic impacts. Surg
Infect (Larchmt). 16:769–774. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bangera D, Shenoy SM and Saldanha DR:
Clinico-microbiological study of Pseudomonas aeruginosa in
wound infections and the detection of metallo-β-lactamase
production. Int Wound J. 13:1299–1302. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
El Zowalaty ME and Gyetvai B:
Effectiveness of Antipseudomonal Antibiotics and Mechanisms of
Multidrug Resistance in Pseudomonas aeruginosa. Pol J
Microbiol. 65:23–32. 2016.PubMed/NCBI
|
|
38
|
Gong YL, Yang ZC, Yin SP, Liu MX, Zhang C,
Luo XQ and Peng YZ: Analysis of the pathogenic characteristics of
162 severely burned patients with bloodstream infection. Zhonghua
Shao Shang Za Zhi. 32:529–535. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
39
|
Kim YH: Conditional probability analysis
of multidrug resistance in Gram-negative bacilli isolated from
tertiary medical institutions in South Korea during 1999-2009. J
Microbiol. 54:50–56. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Grewal US, Bakshi R, Walia G and Shah PR:
Antibiotic susceptibility profiles of non-fermenting gram-negative
Bacilli at a Tertiary Care Hospital in Patiala, India. Niger
Postgrad Med J. 24:121–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Azimi A, Peymani A and Pour PK: Phenotypic
and molecular detection of metallo-β-lactamase-producing
Pseudomonas aeruginosa isolates from patients with burns in
Tehran, Iran. Rev Soc Bras Med Trop. 51:610–615. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Dogonchi AA, Ghaemi EA, Ardebili A,
Yazdansetad S and Pournajaf A: Metallo-β-lactamase-mediated
resistance among clinical carbapenem-resistant Pseudomonas
aeruginosa isolates in northern Iran: A potential threat to
clinical therapeutics. Ci Ji Yi Xue Za Zhi. 30:90–96.
2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ismail SJ and Mahmoud SS: First detection
of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among
Pseudomonas aeruginosa isolated from Iraqi hospitals. Iran J
Microbiol. 10:98–103. 2018.PubMed/NCBI
|
|
44
|
Kuti JL, Wang Q, Chen H, Li H, Wang H and
Nicolau DP: Defining the potency of amikacin against Escherichia
coli, Klebsiella pneumoniae, Pseudomonas
aeruginosa, and Acinetobacter baumannii derived from
Chinese hospitals using CLSI and inhalation-based breakpoints.
Infect Drug Resist. 11:783–790. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sader HS, Dale GE, Rhomberg PR and Flamm
RK: Antimicrobial Activity of Murepavadin Tested against Clinical
Isolates of Pseudomonas aeruginosa from the United States,
Europe, and China. Antimicrob Agents Chemother. 62: pii:e00311–18.
2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yang X, Xing B, Liang C, Ye Z and Zhang Y:
Prevalence and fluoroquinolone resistance of Pseudomonas
aeruginosa in a hospital of South China. Int J Clin Exp Med.
8:1386–1390. 2015.PubMed/NCBI
|
|
47
|
Meletis G and Skoura L: Polymyxin
Resistance Mechanisms: From Intrinsic Resistance to Mcr Genes.
Recent Pat Antiinfect Drug Discov. 13:198–206. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Teo JQ, Chang CW, Leck H, Tang CY, Lee SJ,
Cai Y, Ong RT, Koh TH, Tan TT and Kwa AL: Risk factors and outcomes
associated with the isolation of polymyxin B and
carbapenem-resistant Enterobacteriaceae spp.: A case-control
study. Antimicrob Agents. 53:657–662. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zhan Y, Ma N, Liu R, Wang N, Zhang T and
He L: Polymyxin B and polymyxin E induce anaphylactoid response
through mediation of Mas-related G protein-coupled receptor X2.
Chem Biol Interact. 308:304–311. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li S, Jia X, Li C, Zou H, Liu H, Guo Y and
Zhang L: Carbapenem-resistant and cephalosporin-susceptible
Pseudomonas aeruginosa: a notable phenotype in patients with
bacteremia. Infect Drug Resist. 11:1225–1235. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Humphries RM and Hindler JA: Emerging
Resistance, New Antimicrobial Agents ... but No Tests! The
Challenge of Antimicrobial Susceptibility Testing in the Current US
Regulatory Landscape. Clin Infect Dis. 63:83–88. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Meletis G, Tzampaz E, Sianou E, Tzavaras I
and Sofianou D: Colistin heteroresistance in
carbapenemase-producing Klebsiella pneumoniae. J Antimicrob
Chemother. 66:946–947. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tan TY and Ng LS: Comparison of three
standardized disc susceptibility testing methods for colistin. J
Antimicrob Chemother. 58:864–867. 2006.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gales AC, Reis AO and Jones RN:
Contemporary assessment of antimicrobial susceptibility testing
methods for polymyxin B and colist in: review of available
interpretative criteria and quality control guidelines. J Clin
Microbiol. 39:183–190. 2001.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Giamarellos-Bourboulis EJ, Sambatakou H,
Galani I and Giamarellou H: In vitro interaction of colistin and
rifampin on multidrug-resistant Pseudomonas aeruginosa. J
Chemother. 15:235–238. 2003.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zakuan ZD and Suresh K: Rational use of
intravenous polymyxin B and colistin: A review. Med J Malaysia.
73:351–359. 2018.PubMed/NCBI
|
|
57
|
Rojas LJ, Salim M, Cober E, Richter SS,
Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD,
et al: Colistin Resistance in Carbapenem-Resistant Klebsiella
pneumoniae: Laboratory Detection and Impact on Mortality. Clin
Infect Dis. 64:711–718. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lee JY and Ko KS: Mutations and expression
of PmrAB and PhoPQ related with colistin resistance in
Pseudomonas aeruginosa clinical isolates. Diagn Microbiol
Infect Dis. 78:271–276. 2014.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Yamazumi T, Pfaller MA, Messer SA, Houston
AK, Boyken L, Hollis RJ, Furuta I and Jones RN: Characterization of
heteroresistance to fluconazole among clinical isolates of
Cryptococcus neoformans. J Clin Microbiol. 41:267–272.
2003.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Plipat N, Livni G, Bertram H and Thomson
RB Jr: Unstable vancomycin heteroresistance is common among
clinical isolates of methiciliin-resistant Staphylococcus
aureus. J Clin Microbiol. 43:2494–2496. 2005.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Tomasz A, Nachman S and Leaf H: Stable
classes of phenotypic expression in methicillin-resistant clinical
isolates of staphylococci. Antimicrob Agents Chemother. 35:124–129.
1991.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Hermes DM, Pormann Pitt C, Lutz L,
Teixeira AB, Ribeiro VB, Netto B, Martins AF, Zavascki AP and Barth
AL: Evaluation of heteroresistance to polymyxin B among
carbapenem-susceptible and -resistant Pseudomonas
aeruginosa. J Med Microbiol. 62:1184–1189. 2013.PubMed/NCBI View Article : Google Scholar
|
